- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech High Growth Potential Companies
Norwegian Pharmaceuticals & Biotech High Growth Potential Companies
Results
3
Companies with a Future performance score of at least 3, ordered by Future performance score.
3 companies
ArcticZymes Technologies
Market Cap: NOK 809.5m
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally.
AZT
NOK 15.85
7D
-1.6%
1Y
-38.1%
Photocure
Market Cap: NOK 1.3b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 50.20
7D
-1.2%
1Y
-23.5%
Navamedic
Market Cap: NOK 388.6m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 22.00
7D
3.3%
1Y
-35.1%